Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

By Van Driessche Ann   Van de Velde Ann   Nijs Griet   Braeckman Tessa   Stein Barbara   De Vries Jolanda   Berneman Zwi   Van Tendeloo Viggo  

Cytotherapy, Vol. 11, Iss. 5, 2009-09 ,pp. : 653-658

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia

By Kobbe G   Fenk R   Neumann F   Bernhardt A   Steidl U   Kondakci M   Graef T   Aivado M   Vaupel M   Huenerlituerkoglu A-N   Kronenwett R   Pape H   Hildebrand B   Germing U   Haas R  

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 533-542

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Reduced total number of cobblestone area forming cells and in vitro stromal-cell growth in autografts from acute myeloid leukemia patients

By Olesen G.   Tønder H.   Hokland P.  

Cytotherapy, Vol. 2, Iss. 3, 2000-03 ,pp. : 201-209

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 151-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma

By Guardino Ae   Rajapaksa R   Ong Kh   Sheehan K   Levy R  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 277-289

Ashgate Publishing Ltd

Access to resources Recommend Favorite